These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 32572548)

  • 41. Total body aromatization in postmenopausal breast cancer patients is strongly correlated to plasma leptin levels.
    Geisler J; Haynes B; Ekse D; Dowsett M; Lønning PE
    J Steroid Biochem Mol Biol; 2007 Apr; 104(1-2):27-34. PubMed ID: 17350249
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
    Geisler J; Suzuki T; Helle H; Miki Y; Nagasaki S; Duong NK; Ekse D; Aas T; Evans DB; Lønning PE; Sasano H
    J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):237-41. PubMed ID: 19883757
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estrogens and Glucocorticoids in Mammary Adipose Tissue: Relationships with Body Mass Index and Breast Cancer Features.
    Laforest S; Pelletier M; Denver N; Poirier B; Nguyen S; Walker BR; Durocher F; Homer NZM; Diorio C; Andrew R; Tchernof A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1504-16. PubMed ID: 31853538
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Breast cancer resistance protein exports sulfated estrogens but not free estrogens.
    Imai Y; Asada S; Tsukahara S; Ishikawa E; Tsuruo T; Sugimoto Y
    Mol Pharmacol; 2003 Sep; 64(3):610-8. PubMed ID: 12920197
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The endometrial cancer cell lines Ishikawa and HEC-1A, and the control cell line HIEEC, differ in expression of estrogen biosynthetic and metabolic genes, and in androstenedione and estrone-sulfate metabolism.
    Hevir-Kene N; Rižner TL
    Chem Biol Interact; 2015 Jun; 234():309-19. PubMed ID: 25437045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differential effects of progestins on breast tissue enzymes.
    Pasqualini JR
    Maturitas; 2003 Dec; 46 Suppl 1():S45-54. PubMed ID: 14670645
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Concentrations of estrone, estradiol, and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and postmenopausal breast cancer patients.
    Pasqualini JR; Chetrite G; Blacker C; Feinstein MC; Delalonde L; Talbi M; Maloche C
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1460-4. PubMed ID: 8636351
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Estradiol formation by human osteoblasts via multiple pathways: relation with osteoblast function.
    Janssen JM; Bland R; Hewison M; Coughtrie MW; Sharp S; Arts J; Pols HA; van Leeuwen JP
    J Cell Biochem; 1999 Dec; 75(3):528-37. PubMed ID: 10536374
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inhibitors of type 1 17beta-hydroxysteroid dehydrogenase with reduced estrogenic activity: modifications of the positions 3 and 6 of estradiol.
    Tremblay MR; Boivin RP; Luu-The V; Poirier D
    J Enzyme Inhib Med Chem; 2005 Apr; 20(2):153-63. PubMed ID: 15968820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The contribution of 17beta-hydroxysteroid dehydrogenase type 1 to the estradiol-estrone ratio in estrogen-sensitive breast cancer cells.
    Zhang CY; Chen J; Yin DC; Lin SX
    PLoS One; 2012; 7(1):e29835. PubMed ID: 22253796
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aromatase inhibitors: assessment of biochemical efficacy measured by total body aromatase inhibition and tissue estrogen suppression.
    Lønning PE; Geisler J
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):196-202. PubMed ID: 17996443
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel insight in estrogen homeostasis and bioactivity in the ACI rat model of estrogen-induced mammary gland carcinogenesis.
    Pemp D; Esch HL; Hauptstein R; Möller FJ; Zierau O; Bosland MC; Geppert LN; Kleider C; Schlereth K; Vollmer G; Lehmann L
    Arch Toxicol; 2019 Jul; 93(7):1979-1992. PubMed ID: 31119341
    [TBL] [Abstract][Full Text] [Related]  

  • 53. On the significance of in situ production of oestrogens in human breast cancer tissue.
    Blankenstein MA; Maitimu-Smeele I; Donker GH; Daroszewski J; Milewicz A; Thijssen JH
    J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):891-6. PubMed ID: 1314086
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Estrogen inhibits cell proliferation through in situ production in human thymoma.
    Ishibashi H; Suzuki T; Suzuki S; Moriya T; Kaneko C; Nakata T; Sunamori M; Handa M; Kondo T; Sasano H
    Clin Cancer Res; 2005 Sep; 11(18):6495-504. PubMed ID: 16166425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Multiple steroid metabolic pathways in ZR-75-1 human breast cancer cells.
    Thériault C; Labrie F
    J Steroid Biochem Mol Biol; 1991 Feb; 38(2):155-64. PubMed ID: 2004038
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Breast adipose tissue estrogen metabolism in postmenopausal women with or without breast cancer.
    Savolainen-Peltonen H; Vihma V; Leidenius M; Wang F; Turpeinen U; Hämäläinen E; Tikkanen MJ; Mikkola TS
    J Clin Endocrinol Metab; 2014 Dec; 99(12):E2661-7. PubMed ID: 25215559
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship of body mass index with aromatisation and plasma and tissue oestrogen levels in postmenopausal breast cancer patients treated with aromatase inhibitors.
    Lønning PE; Haynes BP; Dowsett M
    Eur J Cancer; 2014 Apr; 50(6):1055-64. PubMed ID: 24507547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Estrogen metabolism and malignancy: analysis of the expression and function of 17beta-hydroxysteroid dehydrogenases in colonic cancer.
    English MA; Stewart PM; Hewison M
    Mol Cell Endocrinol; 2001 Jan; 171(1-2):53-60. PubMed ID: 11165011
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endogenous estrogens as carcinogens through metabolic activation.
    Yager JD
    J Natl Cancer Inst Monogr; 2000; (27):67-73. PubMed ID: 10963620
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas.
    Takagi M; Miki Y; Miyashita M; Hata S; Yoda T; Hirakawa H; Sagara Y; Rai Y; Ohi Y; Tamaki K; Ishida T; Suzuki T; Ouchi N; Sasano H
    Breast Cancer Res Treat; 2016 Feb; 156(1):45-55. PubMed ID: 26943913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.